
    
      The goal of the protocol is to define the normal humoral and cellular immune responses to
      antigens in volunteers and to define abnormalities of these immune responses in patients with
      immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization
      with antigens will be utilized.
    
  